Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
622.00
609.29
578.66
568.25
594.00
564.69
537.27
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
622.00
609.29
578.66
568.25
594.00
564.69
537.27
Raw Material Cost
1.20
1.28
0.00
0.00
0.00
0.00
0.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
94.17
79.56
68.67
65.26
66.00
66.51
49.01
Selling and Distribution Expenses
158.80
118.22
272.30
110.70
68.00
56.72
54.71
Other Expenses
-4.32
-2.91
23.18
-1.48
-6.50
-6.60
-4.85
Total Expenditure (Excl Depreciation)
211.00
170.00
572.80
161.21
69.00
57.22
55.21
Operating Profit (PBDIT) excl Other Income
411
439.3
5.8999999999999995
407
525
507.5
482.1
Other Income
2.90
21.28
9.48
14.67
78.45
26.26
21.08
Operating Profit (PBDIT)
392.10
449.71
219.28
548.85
439.45
761.33
290.71
Interest
94.17
79.56
68.67
65.26
66.00
66.51
49.01
Exceptional Items
58.80
75.34
-59.97
-50.16
-39.45
111.53
-47.32
Gross Profit (PBDT)
620.80
608.01
0.00
0.00
0.00
0.00
0.00
Depreciation
1.20
1.28
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
356.00
444.21
90.64
433.43
334.00
806.36
194.38
Tax
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
214.00
288.22
30.18
238.35
208.00
543.99
102.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
214.00
288.22
30.18
238.35
208.00
543.99
102.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
142.00
155.99
60.46
195.08
126.00
262.37
92.37
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
356.00
444.21
90.64
433.43
334.00
806.36
194.38
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
6,476.90
6,414.35
6,347.91
6,688.65
6,946.58
6,869.88
6,476.25
Earnings per share (EPS)
0.5
0.67
0.07
0.55
0.47
1.21
0.23
Diluted Earnings per share
0.5
0.67
0.07
0.55
0.47
1.21
0.23
Operating Profit Margin (Excl OI)
62.38%
70.11%
36.26%
94.01%
60.77%
130.17%
50.19%
Gross Profit Margin
57.43%
73.12%
15.66%
76.28%
56.23%
142.8%
36.18%
PAT Margin
34.41%
47.3%
5.21%
41.94%
35.02%
96.33%
18.99%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Dec 2025 is 2.08% vs 5.29% in Sep 2025
Consolidate Net Profit
QoQ Growth in quarter ended Dec 2025 is -19.86% vs 390.29% in Sep 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Dec 2025 is -9.15% vs 104.19% in Sep 2025
Interest
QoQ Growth in quarter ended Dec 2025 is 18.34% vs 15.87% in Sep 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025
Compare Quarterly Results Of Royalty Pharma Plc With
Figures in Million
Consolidate Quarterly Results
Change(USD)
Change(%)
Net Sales
622.00
3,705.40
-3,083.40
-83.21%
Other Operating Income
0.00
0.00
0.00
Total Operating income
622.00
3,705.40
-3,083.40
-83.21%
Raw Material Cost
1.20
2,213.00
-2,211.80
-99.95%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
94.17
120.60
-26.43
-21.92%
Selling and Distribution Expenses
158.80
944.90
-786.10
-83.19%
Other Expenses
-4.32
13.92
-18.24
-131.03%
Total Expenditure (Excl Depreciation)
211.00
3,417.70
-3,206.70
-93.83%
Operating Profit (PBDIT) excl Other Income
411.00
287.70
123.30
42.86%
Other Income
2.90
17.70
-14.80
-83.62%
Operating Profit (PBDIT)
392.10
1,072.20
-680.10
-63.43%
Interest
94.17
120.60
-26.43
-21.92%
Exceptional Items
58.80
-527.80
586.60
111.14%
Gross Profit (PBDT)
620.80
1,492.40
-871.60
-58.40%
Depreciation
1.20
766.80
-765.60
-99.84%
Profit Before Tax
356.00
-343.00
699.00
203.79%
Tax
0.00
-2.90
2.90
100.00%
Provisions and contingencies
0
0
0.00
Profit After Tax
214.00
-340.10
554.10
162.92%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
214.00
-340.10
554.10
162.92%
Share in Profit of Associates
0
0
0.00
Minority Interest
142.00
0.00
142.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
356.00
-340.10
696.10
204.68%
Equity Capital
0
0
0.00
Face Value
0.00
0.01
0.00
Reserves
6,476.90
14,711.30
-8,234.40
-55.97%
Earnings per share (EPS)
0.50
-0.30
0.80
266.67%
Diluted Earnings per share
0.50
-0.30
0.80
266.67%
Operating Profit Margin (Excl OI)
62.38%
7.76%
0.00
54.62%
Gross Profit Margin
57.43%
11.44%
0.00
45.99%
PAT Margin
34.41%
-9.18%
0.00
43.59%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 62.20 Million
in Dec 2025Figures in Million
QoQ Growth in quarter ended Dec 2025 is 2.08% vs 5.29% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 4.71% vs -0.34% in Dec 2024
Quarterly - Consolidate Net Profit
Consolidate Net Profit 35.60 Million
in Dec 2025Figures in Million
QoQ Growth in quarter ended Dec 2025 is -19.86% vs 390.29% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 6.59% vs -53.48% in Dec 2024
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 38.92 Million
in Dec 2025Figures in Million
QoQ Growth in quarter ended Dec 2025 is -9.15% vs 104.19% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 7.81% vs -41.11% in Dec 2024
Quarterly - Interest
Interest 9.42 Million
in Dec 2025Figures in Million
QoQ Growth in quarter ended Dec 2025 is 18.34% vs 15.87% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 42.73% vs 40.43% in Dec 2024
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 62.38%
in Dec 2025Figures in %
QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025
YoY Growth in quarter ended Dec 2025 has improved from Dec 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
